Search Results

You are looking at 91 - 100 of 947 items for :

  • "NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines" x
  • Refine by Access: All x
Clear All
Full access

Bridgett Harr, Joanna Bodmann, and Helen Tackitt

Guidelines in Oncology (NCCN Guidelines) for Survivorship and develop a comprehensive program. A questionnaire was created to address survivorship-specific concerns. An order set was created to highlight available resources. Additionally, evidence

Full access

Kristi Maxwell, Eric A. Severson, Meagan Montesion, Ingrid Marino, Rachel Anhorn, and Bethany Sawchyn

,300 AML cases tested with FoundationOne Heme, 62% had an alteration that is included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), and 91% had a clinically relevant alteration identified that could inform diagnosis, prognosis, or

Full access

Elizabeth Reed, Robin M. Lally, and Roksana Zak

Guidelines in Oncology (NCCN Guidelines) for Breast Cancer direct breast cancer treatment and symptom management, but care of young newly diagnosed women requires providers to combine elements of several guidelines and consider an appropriate order of

Full access

Ami M. Vyas, Hilary Aroke, and Stephen J. Kogut

). Guideline-concordant initial care within 6 months of cancer diagnosis was defined as per NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). A multivariate logistic regression was performed to identify the significant predictors of guideline

Full access

Eric Gratias, David Spangler, and Margaret Rausa

Background: eviCore healthcare uses the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to support its proprietary program for medical oncology drug management. All treatment regimens assigned NCCN Category of Evidence 1, 2A, or 2B

Full access

Heather Katz, Hassaan Jafri, Emilia Cindy Leigh, Layana Biglow, Madhulika Urella, and Maria Tria Tirona

Background: Per the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer (available at NCCN.org ), left ventricular ejection fraction (LVEF) should be evaluated prior to and during treatment with trastuzumab. Optimal

Full access

Zin W. Myint, Rani Jayswal, Ranjana Arora, Gregory P. Monohan, Amit Goldberg, Roger Fleischman, Roger Herzig, Hayder Saeed, Gerhard C. Hildebrandt, and Reshma Ramlal

, and molecular abnormalities using NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML, version 1.2018. Kaplan-Meier plots and Cox regression analyses were utilized. Results: A total of 105 AML patients were included; baseline

Full access

William T. McGivney

transparent, credible, and authoritative NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and NCCN Drugs & Biologics Compendium (NCCN Compendium) begs the question, “why don't all policy decision-makers rely on the evaluative capacity and expert

Full access

Anne A. Eaton, Camelia S. Sima, and Katherine S. Panageas

lives.” 8 The organization publishes the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) that serve as established measures for appropriate disease management in the oncology community. The guidelines also influence the Centers for

Full access

Barbara Todaro

despite appropriate antiemetic treatment or requires additional antiemetic rescue medications. Breakthrough CINV continues to be a concern because it can be difficult to treat. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for